Science Explorer Interactive view Map
Company · Cambridge · United States

RaNA Therapeutics (United States)

ranarx.comROR OpenAlex
Research works
29
▼ 5% vs 2013–17
Citations
415
14.4 per fractional work
Top-10% rate
10.3%
record average 16.5%
Open access
45%
world 28%

Not ranked overall: RaNA Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.35× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.27× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 2.64× its world share, 0 worksImmunology and Micro…Neuroscience: 4.91× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.60× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.43× its world share, 0 worksChemistryComputer Science: 0.39× its world share, 0 worksComputer ScienceEngineering: 0.53× its world share, 1 worksEngineeringMaterials Science: 3.26× its world share, 2 worksMaterials SciencePhysics and Astronomy: 0.45× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.08× its world share, 0 worksHealth ProfessionsMedicine: 1.54× its world share, 5 worksMedicineNursing: 0.45× its world share, 0 worksNursingSocial Sciences: 0.12× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.6×. Every wedge is a field page.

Which keywords describe research at RaNA Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Immunotherapy, Nanoparticles, Gene Therapy, Tumor Targeting, Cancer Immunotherapy, Tumor Regression and RNA Interference.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Cancer Therapy4▲ 20×12 topics
  2. Immunotherapy3▲ 16×6 topics
  3. Nanoparticles3▲ 8.1×4 topics
  4. Gene Therapy3▲ 40×3 topics
  5. Tumor Targeting3▲ 67×3 topics
  6. Cancer Immunotherapy2▲ 50×2 topics
  7. Tumor Regression2▲ 78×2 topics
  8. Biomedical Applications2▲ 6.0×6 topics
  9. RNA Interference2▲ 57×1 topic
  10. siRNA Delivery2▲ 84×1 topic
  11. Drug Delivery2▲ 11×4 topics
  12. Cancer1▲ 3.3×8 topics
  13. Tumor Microenvironment1▲ 13×4 topics
  14. CAR T Cells1▲ 98×1 topic
  15. Chimeric Antigen Receptor1▲ 98×1 topic
  16. Inflammation1▲ 1.75×6 topics
  17. Cancer Progression1▲ 17×3 topics
  18. Clinical Trials1▲ 5.9×5 topics
  19. Immunity1▲ 11×3 topics
  20. Innate Immunity1▲ 11×3 topics
  21. PET Imaging1▲ 17×2 topics
  22. Nanocarriers1▲ 80×1 topic
  23. Photodynamic Therapy1▲ 22×2 topics
  24. Photothermal Therapy1▲ 41×2 topics
  25. Surface Engineering1▲ 30×1 topic

Which research topics does RaNA Therapeutics (United States) publish most on?

By volume in 2022–2025: RNA Interference and Gene Delivery, CAR-T cell therapy research, Nanoparticle-Based Drug Delivery and Nanoplatforms for cancer theranostics.

RNA Interference and Gene Delivery: 1 fractional worksCAR-T cell therapy research: 1 fractional worksNanoparticle-Based Drug …1Nanoparticle-Based Drug Delivery: 1 fractional worksNanoplatforms for cancer…1Nanoplatforms for cancer theranostics: 1 fractional worksAdvanced biosensing and bioanalysis techniques: 1 fractional worksSleep and Wakefulness Research: 0 fractional worksComputational Drug Disco…0Computational Drug Discovery Methods: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksGenetic Neurodegenerative Diseases: 0 fractional worksCancer Research and Treatments: 0 fractional works
Molecular BiologyOncologyBiomaterialsBiomedical Engineering4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 RNA Interference and Gene Delivery Molecular Biology 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Nanoparticle-Based Drug Delivery Biomaterials 1 works
  4. 4 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  5. 5 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
  6. 6 Sleep and Wakefulness Research Cognitive Neuroscience 0 works
  7. 7 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  8. 8 Protein Degradation and Inhibitors Molecular Biology 0 works
  9. 9 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
  10. 10 Cancer Research and Treatments Biotechnology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.0%not open55.0%

World: 28% of research is openly available.

with international co-authors36.2%domestic only63.8%

World: 19% is written across borders.

How has RaNA Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 5% lower than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.